GLG
Get Started
GLG

Healthcare Leadership: 3 Takeaways from 2020

More than forty senior healthcare executives recently convened virtually at the GLG Institute Healthcare Leadership Summit, against a backdrop of the pandemic and intense global, social, and political changes. Throughout the day, healthcare experts reflected on how the industry has changed in the last year, and how leaders can collaborate to improve the efficacy of […]

Covid-19 Vaccines and Therapeutics: Where We Stand Now

A huge amount of work and investment has gone into the development of diagnostics, new treatments, and vaccines to combat COVID-19. There is also an unparalleled level of collaboration at all levels that will be critical to achieving success in our fight against the pandemic. Hopefully, these collaborations, along with regional and global coordination efforts, […]

Is Asian Healthcare on the Verge of a Digital Revolution?

What will the future of healthcare in Asia look like? To find out what might be, Dr. Snehal Patel, Co-Founder and CEO at MyDoc and Co-Founder and Director of Galen Growth, Asia, led a conversation with Jeff Chen, Chief Innovation Officer at Fullerton Healthcare Group and former Chief Strategy Officer at Tencent-backed WeDoctor, and Dr. […]

J.P. Morgan Healthcare 2021: How to Make the Most of This Year’s Virtual Conference

The J.P. Morgan Healthcare Conference is going virtual in 2021. The conference, which attracts upward of 20,000 people, is one of the biggest biotech deal-making events. It’s considered an essential event for industry executives, bankers, analysts, and private and public investors. It’s been criticized as being too crowded, too expensive, and too busy. Some San […]

The 2021 Physician Staffing Outlook

The COVID-19 pandemic has been felt in every corner of the health care market. To look at how it has affected the physician staffing business, as well as for a view of how that sector will fare in 2021, GLG recently spoke with Mark Switaj, former chief operating officer of the North Division at Envision […]

The Nutraceuticals Market Is Booming. Will It Last?

The dietary supplement market has seen explosive growth this year, due, in large part, to the pandemic. But even before COVID-19, nutraceuticals were growing at about 6% to 7% year over year. Is this trend likely to continue? And will the nutraceuticals market need to adapt to evolving consumer demands to maintain this demand? GLG […]

Ebook: The Rise of Telemedicine: Survey and Perspectives

The U.S. telemedicine market surged in the first half of 2020. A July HHS report showed an increase from 0.1% of all Medicare primary care visits being facilitated through telehealth in February exploding to 43.5% by April. Decreased regulation coupled with lockdowns and limited access to traditional in-person care dramatically increased adoption. Companies quickly jumped […]

The Future of the ACA in a Post-Ginsburg World

Shortly after the November election, the U.S. Supreme Court is scheduled to hear oral arguments in the case of Texas v. Azar, on which the future of the Affordable Care Act hinges. With the confirmation of Judge Amy Coney Barrett to fill the seat left vacant by the passing of Justice Ruth Bader Ginsburg, the […]

COVID-19 Vaccine Update: The Global Connection and Public Health Issues

In this second part of our COVID-19 vaccine update, GLG’s Michael Weissman, V.P. and Healthcare Content Team Leader, continues to unpack developments concerning the pandemic with three public health experts: Dr. Rachel Sherman, an infectious disease physician who most recently served as principal deputy commissioner at the Food and Drug Administration; Dr. Michael Osterholm, Director of […]

COVID-19 Update: The Race for a Vaccine  

With the coronavirus pandemic dominating the news, GLG recently met with three medical and public experts for their views on several aspects of the crisis, including those related to vaccines and public health policy. The three experts are: Dr. Rachel Sherman, an infectious disease physician who most recently served as principal deputy commissioner at the […]

Is the Fertility Solutions Space Due for a Recovery Soon?

The fertility field has come a long way since the first baby conceived by in vitro fertilization (IVF) was born in 1978. To get a handle on the industry and see where it is going, GLG spoke with Rick Dietz, former Interim CEO of IntegraMed and former Executive Vice President and Chief Business Officer at […]

Speaker Biographies

Hilary Malone PhD, has over 25 years of experience in global drug development, regulatory &government affairs, manufacturing and commercialization within the biopharma industry. Hilary hassignificant board level and executive committee experience including large scale organizationalrestructuring/transformation/integration, major M&A, biotech start-up, capital raising, investorrelations and pre-IPO.​

Hilary is currently CEO of Stylus Medicine, a private genetic medicine biotech company. Previously sheserved as CEO of a Series-A neuroscience company. Prior to these roles, Hilary served as COO & EVP atValo Health Inc., Chief Regulatory Officer & SVP at Sanofi Inc., and Chief Regulatory Officer & SVP atPfizer and Wyeth. Previous experience also includes senior regulatory and drug development roles atReata Pharmaceuticals Inc., AstraZeneca plc and GlaxoSmithKline plc.​

Hilary also serves on the Board of Directors of Hansa Biopharma and Adthera Bio. Hilary holds a PhD inMolecular Neuropharmacology and a BSc in Physiology.

Dr. Thomas Lönngren is Director at his own company PharmaExec Consulting AB. He is the Chairman of the Board of directors at Egetis Therapeutics AB, Sweden. Dr Lönngren also serves as board member at Compass Pathways PLC, London UK and NDA Group, Sweden. He acts as advisor to the following companies and organizations: NDA group, Sweden, Sweden, Artis Venture, San Francisco, US, Fujimoto Japan, Skin2Neuron Pty Ltd, Sydney, Australia, US, Special advisor to the Centre for Innovation in Regulatory Science (CIRS), London UK. From 2001 until2011, Mr.Lönngren served as the Executive Director of the European Medical Agency. He was previously Deputy General Director of the Swedish Medical Product Agency until 2000. He has a degree in pharmacy and MSc in Social and Regulatory Pharmacy from Uppsala University. He is also an Honorary Member of the Royal Pharmaceutical Society of Great Britain, Honorary Fellow of the Royal College of Physicians in Great Britain, Honorary Doctorate from the University of Uppsala, Honorary Doctorate from University of Bath, UK.

Speaker Biographies

Marie-Anne Aymerich

Marie-Anne has built a portfolio of senior advisory and non-executive roles, following a successful international career in the FMCG and Luxury sectors. She is a non-executive director of Haleon, a FTSE100 company listed in 2022 after the demerger from GSK. She is also chairwoman of Haleon Environment and Societal Sustainability committee. She is the executive director of the Pierre Fabre Group where she also sits on the Strategic Committee, and she is a Board Member of The Academy of St. Martin-in-the-Fields, one of the world’s most prestigious chamber orchestras. She is also an angel investor and focuses her time and investments on start-ups with the strongest purpose and impact.

Marie-Anne is also a regular lecturer at HEC Paris on purposeful leadership, and she has created a serious game called “Planet Purpose” to upskill people on sustainability and purpose. Throughout her 35year executive career she delivered a strong track-record of business performance and growth in brands and portfolio in both developed and emerging economies.

As a senior leader with Unilever, she led a number of different personal care categories across France, Spain and the USA – including managing the Dove brand worldwide and culminating in leading Unilever’s global Oral Care division. She also worked for LVMH as Brand General Manager of Dior Perfumes and Cosmetics worldwide. Marie-Anne was also Vice-President of Imagine for Margo – Children with Cancer for ten years, a charity she helped found in 2011 with the goal of eradicating children’s cancer. The charity is the #1 charity focused on child cancer in France and has fundraised more than €14m since its creation. Marie-Anne is a graduate from HEC Paris. She is married and has two children aged 29 and 26.

Patrick Jephson

Patrick Jephson is a consultant, journalist, broadcaster and New York Times bestselling author, based in Washington D.C. He is a published authority on corporate and personal branding and crisis communications, addressing conferences worldwide as well as events at the U.S. State Department, the American University and the Annenberg School for Communication and Journalism.

With more than twenty-five years’ experience in the government, luxury and family office sectors, Patrick’s portfolio has included globally admired brands as well as national agencies and NGOs. He has also worked on reputation and legacy briefs with European, Middle Eastern and Asian families, including royalty. He now writes, presents, and advises on factual and drama TV programs, appearing on every major American and many international networks. He was recently an expert consultant to the award-winning Netflix series The Crown and provided live commentary on the Coronation of King Charles.

Patrick owes much of his practical communications and protocol experience to Princess Diana, who chose him to be her equerry and only private secretary/chief of staff. He served the Princess for eight years, responsible for all aspects of her public life, global humanitarian initiatives, and private organization. Having worked for an internationally high-profile woman (and as the father of two professionally successful daughters) he feels a special affinity for cross-cultural, gender and perception issues.

Patrick was born and raised in Ireland and holds a master’s degree in political science from Cambridge University. As an officer in the British Royal Navy, he served all over the world before being selected for royal duty. He is a citizen of the U.K., U.S.A., Ireland, and Canada.